More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

Recruiting N/A Interventional Study
Acute Lymphatic Leukemia Lymphoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
180 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In this study, we investigate the cardiopulmonary health of survivors who underwent cancer treatment for acute lymphoblastic leukemia (ALL) or lymphoma during childhood, compared with healthy controls. Modern imaging techniques (MRI, MSOT, and echocardiography) as well as questionnaires assessing cardiopulmonary and mental health are used.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Control Group: Inclusion Criteria: * no cancer diagnosis * no lung diseases * no vascular diseases * No subjective reduction in physical performance * age \>/= 18 years Exclusion Criteria: * Pregnancy, Lactation * Known pleural or pericardial effusion * Critical condition (requiring respiratory …
Contacts

Axel Karow, PD. Dr. med.

09131 8533118

axel.karow@uk-erlangen.de

CONTACT

Ferdinand Knieling, Prof. Dr. med.

09131 8533118

ferdinand.knieling@uk-erlangen.de

CONTACT